The CAGR for the pharmaceutical packaging market demand from 2024 to 2034 is calculated to stand at 3.2%. Covering the ongoing need for medication and its packaging solutions, the market is set to reach a valuation of USD 108.9 billion in 2024.
The promising nature of the pharma sector in emerging economies has set an uptrend in its market valuation, doubling to USD 149.8 billion by 2034.
| Attributes | Key Statistics |
|---|---|
| Expected Base Year Value (2024) | USD 108.9 billion |
| Anticipated Forecast Value (2034) | USD 149.8 billion |
| Estimated Growth (2024 to 2034) | 3.2% CAGR |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
Soaring demand for pharmaceutical products with the rise in population and growing prevalence of chronic diseases has surged the market. For instance, in the United States, pharmaceutical sales as a whole exceeded USD 500 billion in 2023. This has literally increased the demand for pharmaceutical packaging solutions designed to protect the products from external factors.
The growth of pharmaceutical pouches and closures is also driven by the adoption of innovative packaging technologies in developed countries like the United States. Manufacturers are increasingly focusing on developing advanced packaging solutions that offer better protection and functionality.
For instance, smart packaging solutions equipped with sensors and tracking technologies are gaining popularity. These solutions provide real-time product monitoring, help reduce waste, and improve supply chain efficiency.
In light of environmental sustainability, demand for eco-friendly packaging solutions is also visible in the pharmaceutical landscape. This also contributes to the rapid adoption of sustainable pharmaceutical packaging solutions.
The surging need for packaging solutions that are biodegradable, recyclable, and made from renewable sources is foreseen to drive the packaging market. This has led to the development of biodegradable plastics, paper-based packaging, and compostable materials, which are gaining popularity among pharmaceutical companies.
Manufacturers are increasingly focused on developing packaging solutions that offer durability, functionality, and cost-effectiveness. Development of innovative packaging solutions such as blister packs, pouches, and sachets is aimed at reducing packaging costs and improving supply chain efficiency.
ViiV Healthcare reported in February 2024 that Dovato is going to be available in the United States in an updated blister pack design. These solutions are propelling the sales of cost-effective packaging solutions in the pharma sector.
Some factors affect the pharmaceutical packaging market against the ongoing growth of the pharma sector:
Bottles offer a wide range of options in terms of size, shape, and material. This makes them preferred choices in various types of pharmaceutical products like pills, capsules, tablets, and liquids. Due to this quality, bottles dominate the pharmaceutical bottle market with a market share of 33.10% for 2024.
| Attributes | Details |
|---|---|
| Product Type | Bottles |
| Market Share (2024) | 33.10% |
In the pharmaceutical packaging market share, bottles are also popular because of their ability to protect the quality and integrity of the products they contain. Most pharmaceutical products need protection from light, moisture, and air. These factors cause the degradation of products and affect their efficacy.
Bottles are designed likewise to protect the content from external factors. Thus, the market demand for bottles is high. Additionally, bottles are tamper-evident. All these factors make bottles a crucial product type in packaging in the pharmaceutical industry.
Properties like high durability and light weight make plastics a dominating material type in the market. Overtaking the market, it is set to acquire a market share of 58.20% in 2024.
| Attributes | Details |
|---|---|
| Material Type | Plastics |
| Market Share (2024) | 58.20% |
Plastic materials are ideal for packaging small products like pills and capsules. It also provides a long shelf life and can withstand exposure to various environmental conditions.
Plastics can be easily sterilized, making them suitable for packaging medical equipment and devices. Thus, the plastic pharmaceutical packaging market size is progressing fast, markedly in developed countries like the United States and Germany.
The use of plastics has become increasingly popular due to the rising requirement for cost-effective solutions without compromising on quality in the pharmaceutical industry. The market for plastic packaging is likely to grow in coming years with increasing demand for over-the-counter medications and expansion of the pharma sector in emerging economies.
Countries like the United States, India, China, Thailand, the United Kingdom, and Spain are expanding broadly in the pharmaceutical packaging landscape.
| Countries | CAGR from 2024 to 2034 |
|---|---|
| India | 5.6% |
| China | 4.7% |
| Thailand | 4.1% |
| Spain | 3.6% |
| United Kingdom | 3.1% |
| United States | 2.8% |
Ongoing expansion of the pharmaceutical industry in the country, coupled with the continuous development of new drugs and increased investment, is expected to drive pharmaceutical demand throughout the assessment period. With a larger manufacturing base, the market in the Unites States upsurges at a CAGR of 2.8% through 2034.
The Unites States is a hub for drug production; it commercializes cutting-edge therapies with advanced packaging solutions to cater to specific needs. Escalating the development of novel drugs enhances the demand for pharmaceutical packaging solutions. This overall increases product sales, uplifting the country’s presence in the global market.
Presence of big manufacturers of pharmaceutical plastic bottles in the country, such as AptarGroup Inc., Gerresheimer AG, Amcor Ltd., and Berry Plastics Group, Inc., has a positive impact on the pharmaceutical plastic bottles market.
India is one of the prominent players in the pharmaceutical industry, particularly in generic drugs and affordable medicine. India holds a global share in pharma production with a remarkable CAGR of 5.6% through 2034.
India serves as a crucial supplier of generic medicines to over 200 countries. The escalating production and global export of generic drugs are major catalysts propelling the growth of India's medicinal packaging industry.
The ready accessibility of raw materials, including plastic and paper, coupled with supportive government initiatives, is enticing leading pharmaceutical packaging manufacturers to broaden their footprint in India.
Market players like Amcor, Gerresheimer AG, Origin Pharma Packaging, Nelipak, and West Pharmaceutical Services are among the leading manufacturers of drug packaging worldwide.
Origin Pharma Packaging has been an innovative packaging company for nearly 60 years. This company has a portfolio of in-house manufactured components fostered by a holistic supply solution. They are involved in smart packaging and child-resistant and senior-friendly packaging.
The rapid expansion of China’s pharmaceutical industry, driven by a growing aging population and escalating healthcare requirements, has taken drug production and packaging solutions in a new direction. With a CAGR of 4.7%, China has contributed to the overall growth of the pharmaceutical packaging industry Demand.
Growing consumer awareness about the importance of safe and effective drug delivery has increased the demand for advanced packaging for pharmaceutical products that ensures product integrity, safety, and proper dosage administration. Shortage of labor issues in big cities of China has forced pharma companies to rethink how they manufacture.
China is also among the big exporters of its packaging solutions, especially pharmaceuticals, to Vietnam, Pakistan, and beyond. Gerresheimer Shuangfeng Pharmaceutical Glass (Danyang) Co. Ltd (Gerresheimer AG), West Pharmaceutical Services Inc., Taishan Xinhua Pharmaceutical Packaging Co. Ltd, and Ningbo Zhengli Pharmaceutical Packaging are among the top packaging companies in China.
Advances in pharmaceutical technology and suppliers of therapeutic packaging, containers, and containment solutions have positioned Thailand as a key player in the pharma sector. With a CAGR of 4.1% from 2024 to 2034, Thailand is experiencing the continuum growth in the packaging of pharmaceutical products.
Thailand boasts a strategic geographical location, serving as a gateway to the fast-growing Southeast Asian market. Due to this advantage, numerous pharmaceutical companies are attracted to Thailand, seeking in-demand packaging solutions.
Key players in the Thailand pharmaceutical packaging market include Berry Global, Amcor plc, Gerresheimer AG, and Indorama Ventures. These companies offer innovative packaging solutions tailored to the needs of pharmaceutical industries.
Thailand has witnessed a surge in sustainable packaging solutions and the adoption of advanced packaging technologies such as smart packaging, which incorporates features like RFID tags and temperature sensors to ensure product safety and integrity.
Spain is an emerging player in sustainable pharmaceutical packaging solutions, with a CAGR of 3.6% projected through 2034.
Spain has a strong pharmaceutical industry focusing on research and development, resulting in a high demand for packaging solutions. Spain, acting as a gateway to European and international markets, facilitates efficient distribution channels. This allows Spain’s pharmaceutical packaging companies to effectively reach a broad customer base.
Key players in Spain's pharmaceutical packaging market include companies such as Germark, Constantia Flexibles, and SGD Pharma. Advancements in smart packaging technology, including track-and-trace systems and anti-counterfeiting measures, have enhanced product safety and security.
Overall, Spain’s presence in pharma packaging is driven by an innovation-driven approach and meeting the evolving needs of the sector.
Recent trends in pharmaceutical packaging for biologics and anti-counterfeiting features of drugs in the United Kingdom have solidified the country's presence in the market. With a CAGR of 3.1%, the United Kingdom is strengthening its growth in advanced packaging solutions.
Integrating smart packaging technologies, including RFID tags and NFC-enabled labels, has revolutionized supply chain management. This has ensured product authenticity and traceability while combating counterfeit drugs.
Also, the adoption of sustainable packaging and practices aligns with global efforts toward eco-friendly solutions. These factors drive towards recyclable and biodegradable packaging options in the country’s growth.
Key players such as Essentra plc, Origin Pharma Packaging, and Amcor plc have significantly contributed to the market's growth by offering enhanced protection, tamper-evident features, and patient-friendly designs.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
Pharmaceutical packaging manufacturers are actively seeking growth opportunities through the introduction of cutting-edge medicinal packaging solutions featuring varied capacities.
Market leaders are implementing diverse strategies to enhance their global market position, including mergers, partnerships, joint ventures, acquisitions, collaborations, research and development initiatives, and facility expansions.
Recent Advancements
The market is currently valued at USD 108.9 billion in 2024.
The pharmaceutical packaging market is expected to reach USD 149.8 billion by 2034.
The market is set to develop at a CAGR of 3.2% from 2024 to 2034.
Bottles are the top product type in the market, with a share of 33.10% for 2024.
The market in the United States is expected to progress at a CAGR of 2.8% through 2034.
| Market Size (2024) | USD 4.8 billion |
|---|---|
| Market Value (2034) | USD 7.7 billion |
| Market Projected Growth Rate (2024 to 2034) | 4.8% CAGR |
| Market Size (2024) | USD 75,527.4 million |
|---|---|
| Anticipated Market Value (2034) | USD 290,824.8 million |
| Projected CAGR (2024 to 2034) | 14.4% |
| Estimated Market Share in 2023 | USD 6.1 billion |
|---|---|
| Forecasted Market Size by 2033 | USD 11.9 billion |
| Projected Market Growth Rate from 2023 to 2033 | 7.5% CAGR |
| Market Size (2023) | USD 484.8 million |
|---|---|
| Projected Market Value (2033) | USD 812.5 million |
| Market CAGR (2023 to 2033) | 5.3% |
Explore Healthcare Packaging Insights
View Reports
Pharmaceutical Packaging Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
